Our Medical Advisory Committee
 /  Medical Advisory Committee
  • Dr. Victoria Atkinson
    Dr. Victoria Atkinson

    Dr. Victoria Atkinson is a Senior Staff Specialist Medical Oncologist at the Princess Alexandra Hospital since 2007 and Visiting Medical Oncologist at Greenslopes Private Hospital since 2011. Her undergraduate training was undertaken at the University of Queensland and she completed her FRACP in Medical Oncology in 2006. Her tumour interests include Melanoma and Gastro-intestinal tumours.

    She has extensive experience with targeted therapies for Melanoma including Vemurafenib, Dabrafenib, Trametinib and Ipilimumab, Nivolumab and Pembrolizumab and is involved in clinical trials with these therapies at both sites.

  • Professor Jonathan Cebon
    Professor Jonathan Cebon

    Jonathan Cebon is the Medical Director of the Cancer Services Unit at the Olivia Newton-John Cancer & Wellness Centre (ONJCWC) at Austin Health in Heidelberg Victoria and Medical Director of the Olivia Newton-John Cancer Research Institute. His clinical area of interest is the immune therapy of cancer. (more…)

  • Professor Georgina Long
    Professor Georgina Long

    Professor Georgina Long, BSc PhD MBBS FRACP, is Chair of Melanoma Medical Oncology and Translational Research at Melanoma Institute Australia (MIA) and Royal North Shore Hospital, The University of Sydney. She leads an extensive clinical trials team and laboratory at MIA, with a focus on targeted therapies and immuno-oncology in melanoma. She is principal investigator on phase I, II and III clinical trials in adjuvant and metastatic melanoma, including trials in patients with active brain metastases.

    She is the chief investigator on NHMRC funded research into the molecular biology of melanoma, with a particular interest in clinical and tissue biomarker correlates of systemic therapy sensitivity and resistance. In recognition of her ground breaking research, Professor Long has received a number of awards, including the prestigious Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research in 2016, and a number of recent CINSW Premier’s Awards for Outstanding Cancer Research: In 2014, she was awarded the Wildfire Award for the most highly-cited, original, peer-reviewed article published in 2011; and in 2013 she was named the Outstanding Cancer Research Fellow. She is the author of over 125 peer-reviewed publications in clinical and translational research in melanoma since 2011, including the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology and Cancer Discovery. Professor Long has presented her work at international conferences and meetings on more than 120 occasions.

    She is Chair of the ASCO Scientific Committee for melanoma and skin cancer, is medical oncology lead for the Australian Melanoma Management Guidelines Committee, is on the editorial boards of several high-impact journals, and is a member of the Melanoma Expert Panel for AJCC Cancer Staging System 8th edition.

    Professor Long was awarded the University Medal in Organic Chemistry. She subsequently completed her PhD in Chemistry in the field of anti-cancer agents and their binding to DNA. She then moved to the USA to take up a Fulbright Postdoctoral Fellowship at Scripps Research Institute, exploring nanotechnology in cancer treatment, before returning to Australia to complete her MBBS (Hons). Professor Long became a Fellow of the Australasian College of Physicians in January 2008, specialising in medical oncology.

  • Professor Grant McArthur
    Professor Grant McArthur

    Professor Grant McArthur is a Fellow of the Royal Australasian College of Physicians and holds a Ph.D. in Medical Biology. He has been appointed the inaugural Lorenzo Galli chair position in Melanoma, University of Melbourne, Co-Head Cancer Therapeutics and Practitioner Fellow NHMRC. In 2004 he was awarded the Translational Research Award of the Foundation Nelia et Amadeo Barletta and presented a plenary paper at the EORTC-NCI-ACCR Symposium on Molecular Targets and Cancer Therapeutics.

    In 2005 he was awarded the Sir Edward Dunlop Clinical Cancer Research Fellowship of the Cancer Council of Victoria. He is national and international study Co-Chair of a number of clinical trials of targeted therapies. His research Interests include clinical trials of targeted therapeutics, personalised medicine, melanoma, cell cycle control, and functional imaging. Professor McArthur is on the Editorial Board for melanoma at Annals of Oncology and sits on the editorial board of Anti-Cancer Drugs, the Journal of Clinical Oncology, the Open Clinical Cancer Journal, Therapeutic Advances in Medical Oncology and the Journal of Personalised Medicine. He has had over 175 publications including senior or first author publications in the following journals: New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, Cancer Discovery, Cancer Cell, Nature, Cell Biology, Blood and EMBO.

  • Professor Mark Smithers
    Professor Mark Smithers

    University of Queensland – Bachelor of Medicine, Bachelor of Surgery 1977
    Fellow of the Royal Australasian College of Surgeons 1985
    Fellow of the Royal College of Surgeons of England 1986
    Fellow, Royal College of Surgeons of Edinburgh (Ad Hom) 2012
    Mayne Professor, Head of Discipline of Surgery, University of Queensland
    Director, Upper Gastro-intestinal and Soft Tissue Unit, Princess Alexandra Hospital.
    Chairman, Queensland Melanoma Project
    Director, Melanoma Patients Australia

    Melanoma interests:
    Surgeon involved in the management of patients with all stages of melanoma for 26 years.
    Senior surgeon at the Melanoma Clinic at the Princess Alexandra Hospital

    Research involvement:
    Epidemiology of melanoma in Queensland – Collaboration with the Queensland Institute of Medical Research, Epidemiology Unit.
    Assessment of the outcomes of patients with high risk primary and secondary melanoma.
    Phase I-III trials in the surgical and medical management of patients with stage III and IV melanoma. These include locally based studies as well as collaboration in national and international trials.

  • Professor Peter Soyer
    Professor Peter Soyer
    Head, South-West Clinical Cluster Deputy Head, School of Medicine Chair, Dermatology Research Centre The University of Queensland

    Professor Peter Soyer has a dual role within the University of Queensland as Head of the South-West Clinical Cluster & Deputy Head of the School of Medicine, and the inaugural Chair and Director of the Dermatology Research Centre at the Translational Research Institute. He is also Director of the Dermatology Department at the Princess Alexandra Hospital. Professor Soyer, an academic dermatologist from Austria, is a world leader in the field of dermatology with particular expertise in the areas of clinical dermatology, dermatooncology, dermatopathology and dermatologic imaging (dermoscopy and reflectance confocal microscopy).

    His research group’s main focus is skin cancer (both non-melanoma skin cancer and melanoma), and he is co-inventor in multiple patents for novel skin delivery platforms and microbiospy sampling devices. He has an extensive publication record with over 600 publications to date (more than 150 publications in the last 5 years) and more than 550 citations a year (in the last 5 years) and a Hirsch index of 63 (Google Scholar). He is past President of the International Society of Dermoscopy and the International Society of Teledermatology and is co-editor in chief of the Australasian Journal of Dermatology. He is lead investigator of the Centre of Research Excellence for the Study of Naevi awarded in December 2015, funded by the Australian Government National Health and Medical Research Council (NHMRC).

  • Professor Jane Turner
    Professor Jane Turner

    Jane Turner is a consultation-liaison psychiatrist who has worked clinically for over 25 years in psycho-oncology. She treats patients with diverse cancer diagnoses and disease stages however has a particular interest in Stage III and IV melanoma including the impact on families, and ways of assisting parents to talk with their dependent children.

    She is serving a second term on the Board of the International Psycho-Oncology Society (IPOS), the peak international body promoting psycho-oncology, Chairs the Guidelines Committee, and is Co-Chair of the WHO Committee of IPOS which has developed a comprehensive program to enhance the status of psychosocial care globally, with a focus on education and capacity-building in low-to middle-income countries. She is a member of the Scientific Advisory Committee of the Psycho-oncology Cooperative Research Group, a member of the Cancer Australia Breast Cancer Advisory Group and Scientific Advisor to Breast Cancer Network of Australia.

    She has been extensively involved in educational initiatives to enhance the confidence and skills of health professionals in providing psychosocial care for people affected by cancer. Her research interests include evaluation of innovative models of psychosocial care provided by front-line health professionals, and promotion of wellness for cancer survivors. She was a member of the Clinical Oncology Society of Australia Working Group that developed the COSA Model of Survivorship Care, launched in 2016. She has recently completed a trial of a nurse-delivered survivorship intervention for patients treated for head and neck cancer. She is an investigator in a multi-site trial of a manual-based psychosocial intervention for patients with breast, colorectal cancer and melanoma with high fear of cancer recurrence.

Stay Connected

Melanoma Patients Australia Ltd shared their post. ... See MoreSee Less

Are you still planning to attend MPA's Cairns melanoma forum? Please note bookings close today. Any questions, call us 1300 88 44 50

View on Facebook

The 'booty' just keeps on growing for our MPA Gala Dinner on 9 June. Buy your tickets at mpagaladinner2017.eventbrite.com/ and on the night you could be taking home a Soleil Pool Bar Signature Garden Tea for 6 thanks to Rydges Hotels & Resorts, cinema space for 24 at Blue Room Cinebar, a Henry Coughlin Photography experience & print or 4 passes for 9 holes at Holey Moley Golf Club (pic below).

Don't miss out on an arresting night of fun!
... See MoreSee Less

View on Facebook

This year's Palliative Care week theme is 'You matter, Your care matters. Palliative care can make a difference’.
So many of us confuse palliative care with end of life care, assuming that death is imminent if we are referred to palliative care. Palliative care embodies wholeness, peacefulness and enhanced quality of life-- pain and symptom management so that you can get on with living as well as you can until you can't. Whether this is for a day, a week or a year is irrelevant compared with the relief found when you can let go of fear and despair even for just 1 hour. Please call MPA 1300 88 44 50 in office hours for more information. #npcw
... See MoreSee Less

View on Facebook

Contact us

Head Office:
Level 8, East Wing
Wesley Research Institute
451 Coronation Dve, Auchenflower QLD 4066
PO Box 1771
Toowong BC QLD 4066

Phone: 1300 884 450
Mail: info@melanomapatients.org.au